Assembly biosciences to present during the 2023 jefferies healthcare conference

South san francisco, calif., may 23, 2023 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that jason okazaki, chief executive officer and president, and william delaney, phd, chief scientific officer, will present in a fireside chat during the 2023 jefferies healthcare conference at 4:00 p.m. eastern time on june 7, 2023. a live webcast will be available on the events and presentations section of assembly bio's website and a replay will be accessible following the event. to register for the live webcast and replay, please visit: https://investor.assemblybio.com/events-presentations.
ASMB Ratings Summary
ASMB Quant Ranking